ArticleBMC medical informatics and decision making2025
Development and validation of a deep learning model for early detection and screening of diabetic retinopathy.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diabetic Retinopathy Detection: AI Models and Approaches.Journal of ophthalmology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Early diagnosis and screening of diabetic retinopathy (DR) are crucial for reducing medical burdens and conserving healthcare resources. This study introduces an advanced AI-assisted recognition system designed to enhance the detection of DR lesions through innovative automatic learning methods. Central to our approach are agnostic text instruction templates, which facilitate zero-shot DR detection by integrating text embeddings with visual information. Our system performs comprehensive lesion detection by leveraging similarity mapping at both the image and patch levels, enabling it to identify a wide range of diabetic retinopathy (DR) lesions without the need for extensive annotated data. This AI-assisted system distinguishes itself from traditional fully supervised models and few-shot learning approaches by addressing the complexities of DR image annotation and safeguarding patient privacy. To validate the system's effectiveness, we conducted extensive experiments across five internal and publicly available test sets, as well as an external test set captured using smartphone devices. Our evaluation involved performance analysis of various pre-training methods, including detailed patch-level visualizations and t-SNE clustering techniques to assess the quality of feature embeddings. The results of our zero-shot experiments reveal that our system outperforms conventional transfer learning-based DR detection methods. This superiority is evident in both the pre-training and testing phases, showcasing the system's ability to deliver accurate and reliable DR lesion detection while circumventing the limitations of traditional approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.